Segment Information (Tables)

12 Months Ended

Sep. 27, 2013

Operating Results Information for Each Business Segment

Accordingly, the following information is provided for purposes of achieving an understanding of operations, but may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.

Segment Data

	Revenues									Operating Earnings
	Fiscal Years									Fiscal Years
(In millions)	2013			2012			2011				2013				2012				2011
Oncology Systems	$	2,253	$		2,189	$		2,022	$			512		$		505		$		507
X-Ray Products		546			493			469				144				131				118
Total reportable segments		2,799			2,682			2,491				656				636				625
Other		144			125			106				(25	)			(32	)			(32	)
Corporate		-			-			-				(22	)			(10	)			(5	)
Total company	$	2,943	$		2,807	$		2,597	$			609		$		594		$		588


	Depreciation & Amortization									Capital Additions
	Fiscal Years									Fiscal Years
(In millions)	2013			2012			2011				2013			2012			2011
Oncology Systems	$	21	$		23	$		19	$			25	$		17	$		17
X-Ray Products		13			10			8				8			8			7
Total reportable segments		34			33			27				33			25			24
Other		3			4			3				10			10			13
Corporate		26			24			23				35			32			34
Total company	$	63	$		61	$		53	$			78	$		67	$		71

	Total Assets									Goodwill
	Fiscal Years									Fiscal Years
(In millions)	2013			2012			2011				2013			2012			2011
Oncology Systems	$	1,217	$		1,220	$		1,093	$			132	$		132	$		130
X-Ray Products		309			265			268				17			17			6
Total reportable segments		1,526			1,485			1,361				149			149			136
Other		367			313			239				76			73			76
Corporate		1,575			1,081			899				-			-			-
Total company	$	3,468	$		2,879	$		2,499	$			225	$		222	$		212

Reconciliation of Segment Operating Results to Companys Earnings from Continuing Operations before Taxes

The reconciliation of segment operating results information to the Company’s earnings from operations before taxes was as follows:

	Fiscal Years
(In millions)	2013				2012				2011
Earnings from operations before taxes:
Oncology Systems	$	512		$		505		$		507
X-Ray Products		144				131				118
Total reportable segments		656				636				625
Other		(25	)			(32	)			(32	)
Corporate		(22	)			(10	)			(5	)
Interest income (expense), net		3				2				1
Total company	$	612		$		596		$		589

Geographic Information

	Revenues									Long-Lived Assets
	Fiscal Years									Fiscal Years
(In millions)	2013			2012			2011				2013			2012			2011
United States	$	1,212	$		1,156	$		975	$			238	$		229	$		223
International		1,731			1,651			1,622				77			68			63
Total company	$	2,943	$		2,807	$		2,597	$			315	$		297	$		286

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, and discontinued operations.

+ References+ Details

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References+ Details

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details